Article: EP MedSystems Receives FDA Clearance for EP-WorkMate with RPM Catheter Navigation Technology.

Business Editors/Health/Medical Writers

WEST BERLIN, N.J.--(BUSINESS WIRE)--Aug. 27, 2003

Company To Receive $1 Million Milestone Payment From Boston

Scientific Corporation

EP MedSystems, Inc. (NASDAQ:EPMD), a market leader in electrophysiology (EP) products used to diagnose and treat certain types of cardiac rhythm disorders, announced today that it received 510k market clearance notification from the U.S. Food and Drug Administration for its integration of Boston Scientific Corporation's RPM(TM) Realtime Position Management(TM) technology with EP MedSystems' EP-WorkMate(R) workstation. The new EP-WorkMate(R) with RPM(TM) will be the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!